Search filters

List of works by Sara Pilotto

ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations

scientific article published on 25 August 2016

ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes.

scientific article published on 16 December 2016

ALK/EML4 fusion gene may be found in pure squamous carcinoma of the lung.

scientific article

Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations

scientific article published on 20 November 2018

Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials

scientific article published on 17 November 2015

Advances towards the design and development of personalized non-small-cell lung cancer drug therapy.

scientific article published on 03 October 2013

An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer

scientific article published on 12 June 2015

Anti-angiogenic drugs and biomarkers in non-small-cell lung cancer: a 'hard days night'.

scientific article published on January 2014

Avoiding chemotherapy for advanced nononcogene addicted NSCLC overexpressing PD-L1: Rule or option?

scientific article published on 01 June 2018

BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

scientific article

Cellular and molecular biology of small cell lung cancer: an overview

scientific article

Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer

article

Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research.

scientific article

Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer.

scientific article published on 17 November 2015

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.

scientific article

Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis

scientific article published on 10 March 2016

Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice.

scientific article published on 29 September 2016

Deciphering Crosstalk Circuits in Non-small Cell Lung Cancers with an Increasing Interval Length of Low Dose CT Screening

scientific article

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

scientific article

Do immune checkpoint inhibitors need new studies methodology?

scientific article

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer.

scientific article

Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome

scientific article published on 01 May 2020

Exercise Levels and Preferences in Cancer Patients: A Cross-Sectional Study

scientific article published on 24 July 2020

Final data of an Italian multicentric survey about counseling for smoking cessation in patients with diagnosis of a respiratory disease

High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers.

scientific article

Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'?

scientific article

Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials.

scientific article

Infections and Immunotherapy in Lung Cancer: A Bad Relationship?

scientific article published on 22 December 2020

Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity

scientific article

Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy number.

scientific article published in December 2013

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer

scientific article published on 11 November 2019

Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.

scientific article published on 22 November 2016

MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy

scientific article published on January 2017

Melanoma: oncogenic drivers and the immune system

scientific article

Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma.

scientific article published in May 2015

Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm

scientific article published in February 2018

Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer

scientific article

Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies

scientific article published on 09 August 2018

Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors

scientific article published in December 2016

Nutritional support in lung cancer: Time to combine immunonutrition with immunotherapy?

scientific article published in 2022

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

scientific article

PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine.

scientific article published on 09 March 2013

Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled?

scientific article published on 26 November 2019

Physical Activity for Oncological Patients in COVID-19 Era: No Time to Relax

scientific article published on 24 August 2020

Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over?

scientific article published on 25 April 2016

Platelets and their role in cancer evolution and immune system

scientific article

Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting

scientific article published on 10 February 2016

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients

scientific article

Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials.

scientific article published on December 2013

Prognostic Model for Resected Squamous-Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment.

scientific article published on 18 December 2017

Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.

scientific article

Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation

scientific article published on 16 June 2017

Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival

scientific article published on 7 July 2016

Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis.

scientific article

Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system

scientific article published on 14 October 2017

Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors

scientific article published on 20 July 2015

Role of mTOR Signaling in Tumor Microenvironment: An Overview

scientific article published on 19 August 2018

Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer

scientific article published on 22 March 2016

Targeting the epidermal growth factor receptor in solid tumors: focus on safety.

scientific article published on April 2014

The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives.

scientific article published on 20 July 2015

Tracking MET de-addiction in lung cancer: A road towards the oncogenic target.

scientific article published on 20 August 2017

Tracking occult pN2 disease after mediastinal dissection in early stage lung cancer

scientific article published in September 2017

Tubulin inhibitors in non-small cell lung cancer: looking back and forward

scientific article published on 21 February 2016

Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex

scientific article published on 01 July 2018

mTOR Cross-Talk in Cancer and Potential for Combination Therapy.

scientific article published on 19 January 2018

Paulina is supported by:

About Paulina

Help